Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 A Billion Reasons Why Innovation Works | Contract Pharma

What are you searching for?

Sign in
Case Studies

A Billion Reasons Why Innovation Works

How Pharma Tech Industries Turned A Complicated Effervescent Transfer Into A Manufacturing Milestone.

Released By Pharma Tech Industries

p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; min-height: 14.0px} p.p2 {margin: 0.0px 0.0px 0.0px 0.0px; text-align: justify; line-height: 12.1px; font: 10.0px Helvetica; color: #00628f} p.p3 {margin: 0.0px 0.0px 0.0px 0.0px; text-align: justify; line-height: 12.1px; font: 10.0px Helvetica; color: #686a6c} p.p4 {margin: 0.0px 0.0px 0.0px 0.0px; text-align: justify; line-height: 10.1px; font: 10.0px Helvetica; color: #686a6c} span.s1 {font: 12.0px Helvetica; color: #000000}

The Situation:
When Johnson & Johnson (J&J) decided to purchase all of Pfizer’s consumer products, including the Efferdent brand, the multinational giant experienced for the first time the complicated intricacies of technology transfer for effervescent products.

 

The Challenge:
The Efferdent brand was being manufactured at a Pfizer facility in Puerto Rico, so J & J required a transfer of the assets to a supplier in its network. However, very few suppliers had a dedicated Technology Transfer Team capable of making the numerous transitions required, while simultaneously maintaining uninterrupted supply deliveries and keeping the process as seamless and precise as possible. 

Download Case Studies Now

Download Case Studies Now

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters